Clinical and Morphological Aspects in Assessing the Safety of OSPL-502 with Repeated Dose Administration | Zendy

Sergey Zhuchkov | Zendy; Alexandr S Kinzirsky | Zendy; I. V. Koroleva | Zendy; Yuriy B Vicharev | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical and Morphological Aspects in Assessing the Safety of OSPL-502 with Repeated Dose Administration

Author(s) -

Sergey Zhuchkov,

Alexandr S Kinzirsky,

I. V. Koroleva,

Yuriy B Vicharev

Publication year - 2018

Publication title -

open access macedonian journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.288

H-Index - 17

ISSN - 1857-9655

DOI - 10.3889/oamjms.2018.398

Subject(s) - medicine , adverse effect , toxicity , drug , no observed adverse effect level , body weight , pharmacology , food consumption , physiology , therapeutic index , acute toxicity , toxicology , agricultural economics , economics , biology

OSPL-502 is a new potential medicinal drug which stimulates a cognitive function. It is necessary to reveal clinical manifestations of its general toxic effect and determine organs that are most heavily affected by this pharmacological substance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research